Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells
- PMID: 1675655
Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells
Abstract
To investigate whether the retargeting of resting CTL can benefit from cooperative signaling between the TCR/CD3 complex and various accessory molecules, such as CD2, CD4, CD5, and CD8, we have constructed a series of trispecific F(ab')3 derivatives. Each derivative was designed to engage effector T lymphocytes with two Fab' arms, and tumor cells with a single Fab' arm. They were constructed by selective coupling of three mAb Fab' fragments, primarily via their hinge-region sulfhydryl groups, using the cross-linker o-phenylenedimaleimide. En route to the production of trispecific F(ab')3 antibodies a range of bispecific F(ab')2 derivatives was first prepared which could bind simultaneously to two different receptor molecules on T cells. Bispecific derivatives containing specificities for (CD2 (T11(1)) x CD3), (CD3 x CD4), (CD3 x CD8) or two epitopes on CD2, ((T11(1) x (T11(3)), all yielded two to three times the uptake of [3H]thymidine with fresh PBMC to that seen with intact IgG from anti-CD3 (OKT3). The exception to these findings was a bispecific F(ab')2 derivative with specificities for (CD3 x CD5) which caused slightly less proliferation than the control reagent, OKT3 IgG. When these bispecific antibodies were converted into trispecific antibodies (TsAb) by the addition of a Fab' from anti-CD37 they were then all able to retarget resting, unprimed, T cells from fresh PBMC for lysis of CD37+ tumor cells. However, the cytotoxic activity of these reagents fell into two distinct groups: group one, containing (anti-CD3 x anti-CD4 x anti-CD37), (anti-CD3 x anti-CD5 x anti-CD37), and (anti-CD3 x anti-CD8 x anti-CD37), gave minimal lysis and behaved in a similar way to the BsAb, (anti-CD3 x anti-CD37), i.e., no evidence of cooperative signaling for lysis; and group two, containing (anti-T11(1) x anti-CD3 x anti-CD37) and (anti-T11(1) x anti-T11(3) x anti-CD37), which were highly cytotoxic and gave up to 80% specific 51Cr-release. The failure of group one TsAb, in particular (anti-CD3 x anti-CD8 x anti-CD37) which should recruit CD8+ CTL, to give efficient lysis despite having anti-T cell arms that were mitogenic as a bispecific antibody, indicates that the cooperative signaling for proliferation is probably distinct from the signal(s) provided by group two TsAb that activate for both proliferation and lysis.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Bispecific F(ab'gamma)3 antibody derivatives for redirecting unprimed cytotoxic T cells.Eur J Immunol. 1991 Jun;21(6):1351-8. doi: 10.1002/eji.1830210604. Eur J Immunol. 1991. PMID: 1828423
-
Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibody.J Immunol. 1995 Sep 15;155(6):2960-71. J Immunol. 1995. PMID: 7673714
-
Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.J Immunol. 1991 Oct 1;147(7):2088-93. J Immunol. 1991. PMID: 1833451
-
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.Int J Cancer Suppl. 1992;7:15-8. Int J Cancer Suppl. 1992. PMID: 1428398 Review.
-
Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.Immunol Rev. 1989 Jun;109:119-41. doi: 10.1111/j.1600-065x.1989.tb00022.x. Immunol Rev. 1989. PMID: 2527803 Review.
Cited by
-
Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.Cell Biophys. 1995 Jun;26(3):153-65. doi: 10.1007/BF02791577. Cell Biophys. 1995. PMID: 8521448 Review.
-
When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy.Theranostics. 2023 Jan 22;13(3):1028-1041. doi: 10.7150/thno.81494. eCollection 2023. Theranostics. 2023. PMID: 36793863 Free PMC article. Review.
-
Cellular signalling mechanisms in B lymphocytes.Biochem J. 1993 Jun 1;292 ( Pt 2)(Pt 2):313-32. doi: 10.1042/bj2920313. Biochem J. 1993. PMID: 8503867 Free PMC article. Review. No abstract available.
-
The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9637-42. doi: 10.1073/pnas.94.18.9637. Proc Natl Acad Sci U S A. 1997. PMID: 9275175 Free PMC article.
-
A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7021-5. doi: 10.1073/pnas.92.15.7021. Proc Natl Acad Sci U S A. 1995. PMID: 7624362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials